These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 24819216)

  • 1. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
    Kanapathipillai M; Brock A; Ingber DE
    Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Immunotherapy to the Tumor Microenvironment.
    Dougan M; Dougan SK
    J Cell Biochem; 2017 Oct; 118(10):3049-3054. PubMed ID: 28332219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer nanoparticulate drug delivery and combination cancer therapy.
    Cao P; Bae Y
    Future Oncol; 2012 Nov; 8(11):1471-80. PubMed ID: 23148619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive drug-delivery systems for tumor targeting.
    He X; Li J; An S; Jiang C
    Ther Deliv; 2013 Dec; 4(12):1499-510. PubMed ID: 24304248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
    Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targeting strategies for chitosan-based nanoparticles.
    Zhang X; Yang X; Ji J; Liu A; Zhai G
    Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.
    Li W; Little N; Park J; Foster CA; Chen J; Lu J
    Mol Pharm; 2021 Aug; 18(8):2889-2905. PubMed ID: 34260250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization.
    Swetha KL; Roy A
    Drug Deliv Transl Res; 2018 Oct; 8(5):1508-1526. PubMed ID: 30128797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Byrne JD; Betancourt T; Brannon-Peppas L
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.